TAYLOR ELLIS: Open Payments
NPI 1740052349 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 88 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $1,632
Food & beverage: $1,632
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $251 |
| Janssen Pharmaceuticals, Inc | 7 | $215 |
| Tris Pharma Inc | 9 | $211 |
| Otsuka America Pharmaceutical, Inc. | 9 | $163 |
| Neurocrine BioSciences, Inc. | 8 | $159 |
| Collegium Pharmaceutical, Inc. | 12 | $149 |
| ABBVIE INC. | 14 | $140 |
| Axsome Therapeutics, Inc. | 5 | $105 |
| Almatica Pharma LLC | 4 | $85 |
| Alkermes, Inc. | 4 | $85 |
Products named: CAPLYTA, SPRAVATO, Dyanavel XR, REXULTI, INGREZZA, Jornay PM, VRAYLAR, Auvelity.
Industry payments across NC — which companies pay providers there.
